Skip to Main Content

Paper Details

The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
Int J Epidemiol
10
2021
ACE, COVID-, COVID-19, COVID-19 disease, Genetic variants, SARS-CoV-2, angiotensin-converting enzyme, genetic variants, serum ACE, serum-ACE
Author NameAffiliation
Guillaume Butler-LaporteCentre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
Guillaume Butler-LaporteMcGill University
Vincent MooserMcGill University
Vincent MooserMcGill University
Vincent MooserMcGill University
Vincent MooserMcGill University
Alessandra RenieriUniversity of Siena
Alessandra RenieriGenetica Medica Azienda Ospedaliera Universitaria Senese
Vincenzo ForgettaCentre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
Vincenzo ForgettaCentre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
John Brent RichardsCentre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
John Brent RichardsMcGill University
John Brent RichardsGraduate School of Medicine, Kyoto University
John Brent RichardsKing's College London
John Brent RichardsCentre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
John Brent RichardsMcGill University
John Brent RichardsGraduate School of Medicine, Kyoto University
John Brent RichardsKing's College London
  • 1 - 18

Datasets

Release 1.2